SMG-SNU Boramae Medical Center
Seoul, 156-707, South Korea
NCT Number: NCT01779648
Various kinds of intermittent pneumatic compression devices (IPC) with particular ways of compression have been developed and used for prevention of deep vein thrombosis.
There are still some controversies about the physiologic properties and clinical impact of numerous issues including the variety of the cuff length, inflation rate, compression sequence, compression-relaxation cycle rate, and pressure generation characteristics.
This study is designed to compare clinical efficacies as well as venous hemodynamic improvements between Simultaneous bilateral compression with fixed venous refill time versus alternate compression with adjusted refill time
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Seoul, 156-707, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Simultaneous sequential intermittent pneumatic compression, Fixed venous refill time
Other names: Alternate and sequential intermittent pneumatic comression, Adjusted venous refill time
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Computed tomographic angiography were performed on 4th postoperative days to detect deep vein thrombosis and evaluate its extent and location.
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared. A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed. Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded. Under fixed state of other ultrasound scan parameters, peak velocity (PV) was measured by determination of maximum point of the augmented waveform.
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared. A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed. Baseline velocity, flow pattern, and augmented flow of 11 seconds (Alternate compression arm) or 12 seconds (Simultaneous compression arm) were recorded. This is an automatically measured mean value of venous flow.
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared. A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed. Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded. Peak volume flow (PVF) was automatically calculated with 1-second interval around the PV.
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared. A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed. Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded. Total volume flow (TVF) was automatically calculated by the software.
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Expelled volume was theoretically calculated value in order to figure out how much blood was squeezed by the compression for an hour; expelled total volume (ETV) = single cycle augmented TVF x cycling rate (cycles/hour).
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Expelled volume was theoretically calculated value in order to figure out how much blood was squeezed by the compression for an hour; expelled peak volume (EPV) = single cycle augmented PVF x cycling rate (cycles/hour).
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Enhanced peak velocity by application of intermittent pneumatic compression
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Enhanced mean velocity by application of pneumatic compression
Time frame: On 4th postoperative days after total knee replacement arthroplasty
Enhanced peak volume flow by application of pneumatic compression
Time frame: on 4th postoperative day after total knee replacement arthroplasty
Enhanced total volume flow by application of pneumatic compression
Time frame: on 4th postoperative day after total knee replacement arthroplasty
Number of cuff inflation-deflation cycle during an hour. In group SF, the cycling rate is fixed as 90 cycles/hour, but in group AA, it is variable according to the individual venous refill time.
Seoul National University Hospital
Other
The Influence of the Different Ways of Pneumatic Compression on Clinical and Physiologic Efficacies in Preventing Deep Vein Thrombosis: a Randomised Comparative Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00839163
Cardiovascular Diseases, Deep Vein Thrombosis
Sydney, New South Wales, Australia
View Trial DetailsNCT02600260
Cardiovascular Diseases, Deep Vein Thrombosis
São Paulo, Brazil
View Trial DetailsNCT03328624
Cardiovascular Diseases, Deep Vein Thrombosis
Los Angeles, California, United States
View Trial DetailsNCT01662908
Cardiovascular Diseases, Deep Vein Thrombosis
Dothan, Alabama, United States
View Trial Details